Insider Shareholders with Direct Ownership of Timber Pharmaceuticals, Inc. (TMBR)
This section provides a comprehensive overview of the insiders with direct ownership of Timber Pharmaceuticals, Inc. (TMBR). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Timber Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Tardi Med Sciences Llc
> 10% Shareholder |
0 | 1,928,950 | 3,508,567 $0 | 18 |
Sep 02, 2021
Reduced 6.03%
|
|
John Koconis
CEO & Chairman |
90,385 | 0 | 70,785 $0 | 2 |
Aug 20, 2023
Added 49.86%
|
|
Zachary Rome
Director |
79,326 | 19,630 | 59,696 $0 | 2 |
Mar 04, 2022
Reduced 24.75%
|
|
Alan Mendelsohn
EVP & CMO |
45,193 | 0 | 35,393 $0 | 2 |
Aug 20, 2023
Added 49.86%
|
|
Joseph Lucchese
EVP & CFO |
35,193 | 0 | 35,193 $0 | 1 |
Aug 20, 2023
Added 50.0%
|
|
Edward J Sitar
Director |
172,827 | 0 | 11,127 $0 | 4 |
Apr 15, 2023
Added 32.38%
|
|
David E Cohen
Director |
104,100 | 0 | 6,100 $0 | 2 |
Apr 15, 2023
Added 40.2%
|
|
Gianluca Pirozzi
Director |
104,100 | 0 | 6,100 $0 | 2 |
Apr 15, 2023
Added 40.2%
|
|
Lubor Gaal
Director |
104,100 | 0 | 6,100 $0 | 2 |
Apr 15, 2023
Added 40.2%
|